title: Blockage of T Cell Activation via Anti-CD40 and Anti-CD154 Monoclonal Antibodies can Possibility Treat Alopecia Areata.
authors.affiliation: Autoimmune Bullous Diseases Research Center, Tehran University of Medical Sciences, Tehran, Iran.|Skin Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
authors.forename: S
authors.initials: S
authors.lastname: Tavakolpour
authors.affiliation: Autoimmune Bullous Diseases Research Center, Tehran University of Medical Sciences, Tehran, Iran.
authors.forename: M
authors.initials: M
authors.lastname: Daneshpazhooh
authors.affiliation: Autoimmune Bullous Diseases Research Center, Tehran University of Medical Sciences, Tehran, Iran.
authors.forename: H R
authors.initials: HR
authors.lastname: Mahmoudi
mesh_terms: D000506:Alopecia Areata / Q000276:immunology / Q000628:therapy*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D001324:Autoantigens / Q000378:metabolism*; D015496:CD4-Positive T-Lymphocytes / Q000187:drug effects* / Q000276:immunology; D019013:CD40 Antigens / Q000276:immunology; D023201:CD40 Ligand / Q000276:immunology; D018414:CD8-Positive T-Lymphocytes / Q000187:drug effects* / Q000276:immunology; D004359:Drug Therapy, Combination; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D008213:Lymphocyte Activation / Q000187:drug effects; D008544:Melanocytes / Q000276:immunology / Q000378:metabolism*
chemical_list: D000911:Antibodies, Monoclonal; D001324:Autoantigens; D019013:CD40 Antigens; D023201:CD40 Ligand